Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-Year Trend Analysis
- 1 April 2008
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 51 (13), 1247-1254
- https://doi.org/10.1016/j.jacc.2007.10.063
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary preventionBMJ, 2005
- Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997Circulation, 2001
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJama-Journal Of The American Medical Association, 2001
- Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populationsThe Lancet, 2000
- Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994The New England Journal of Medicine, 1998
- Improved Outcome of Elderly Patients (≥75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in IsraelCirculation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsThe New England Journal of Medicine, 1996
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionThe New England Journal of Medicine, 1992
- Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart DiseaseJAMA, 1991
- Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial InfarctionThe New England Journal of Medicine, 1988